牙科骨移植替代材料市场－全球产业规模、份额、趋势、机会和预测：按类型、材料、作用机制、产品类型、应用、最终用户、地区和竞争格局划分，2021-2031年

全球牙科骨移植替代材料市场预计将从2025年的9.0828亿美元显着成长至2031年的14.1668亿美元，复合年增长率（CAGR）为7.69%。这些特殊的生物材料可作为支架，促进天然骨再生，并在修復骨缺损的再生手术中发挥关键作用，例如人工植牙和牙周治疗。这一增长主要受全球对牙齿替代解决方案日益增长的需求以及老龄化社会中牙周疾病患病率不断上升的驱动。欧洲牙周病学会联盟（European Federation of Societies of Periodontology）的报告凸显了这一临床需求的规模：到2024年，包括牙周炎和龋齿（蛀牙）在内的可预防性口腔疾病的治疗费用将约占全球医疗费用支出的5%，这凸显了有效干预措施的巨大需求。

然而，儘管市场需求强劲，但由于再生医学手术费用高昂且保险覆盖范围普遍不足，市场仍面临许多限制。在许多地区，保险公司并未全额报销这些先进疗法，导致患者需承担高额自付费用，从而限制了患者的就医途径，尤其是在新兴经济体。因此，高品质骨移植替代材料在低收入者中的广泛应用受到经济挑战的限制。这种经济障碍阻碍了成本敏感地区的市场潜力，并将先进移植疗法的可及性限制在富裕患者群体中。

市场驱动因素

骨移植替代材料市场的主要驱动力是全球人工植牙手术需求的激增。这使得植入的普及与骨再生材料的需求之间形成了直接的依赖关係。由于充足的骨量对于植入的稳定性至关重要，齿槽骨缺损的普遍存在使得骨移植材料的使用成为必要，使其成为现代修復牙科的重要组成部分。这一趋势也体现在主要行业参与者的财务成功上。例如，士卓曼集团在其2025年2月发布的「2024年全年财务报告」中报告称，其收入为25亿瑞士法郎，内部成长率为13.7%，这主要得益于其强劲的植入业务。此外，美国牙医协会（ADA）指出，截至2025年8月，美国消费者在牙科保健方面的支出成长了4%，显示患者对修復牙科的投入持续成长。

第二个关键驱动因素是与人口老化相关的无牙颚和重度牙周病病例的增加。老龄化自然会导致齿槽骨吸收，并增加患有损害颚骨结构的口腔疾病的风险，从而增加对骨重组治疗的需求。重度牙周炎仍然是一项全球性的健康挑战，世界卫生组织（世卫组织）在其2025年3月发布的《口腔健康》概况介绍中估计，全球将有超过10亿例重度牙周病病例。这种疾病的严重程度凸显了再生医学介入的迫切性，随着全球人口老化和复杂口腔健康问题的不断演变，对有效骨移植替代物进行功能性修復的依赖必将增加。

市场挑战

全球牙科骨移植替代材料市场成长的最大障碍是再生医疗手术的高昂费用和缺乏足够的报销。许多保险公司将先进的骨移植手术归类为选择性或美容手术，而非医疗必需项目，导致患者需要承担高额的自付费用。这种经济负担严重阻碍了市场渗透，迫使很大一部分患者选择更便宜的非修復性替代方案或无限期推迟治疗。因此，骨移植替代材料的应用往往仅限于富裕人群，这限制了该市场在新兴经济体和成本敏感型经济体中的潜在扩张。

这种经济障碍导致患者接受专业牙科服务的动机显着下降，造成了专业护理的瓶颈。根据美国牙医协会 (ADA) 2024 年的报告，与其他医疗保健服务相比，牙科护理的费用障碍最为严重，导致只有 40% 的劳动年龄成年人会去看牙医。这项数据凸显了高成本与低利用率之间的直接关联。当经济拮据使患者甚至无法获得基本的牙科服务时，对骨移植等高级、高成本手术的需求必然会受到抑制，从而阻碍整个市场的扩张。

市场趋势

重塑市场格局的关键趋势是数位化工作流程与引导性骨再生技术的融合，进而提升临床精准度与治疗效果。锥状射束CT (CBCT) 与口内扫描的结合，使临床医生能够利用软体驱动的工具精确计算所需骨量并製作定製手术导板，显着提高复杂牙槽骨增容手术的可预测性。该技术的快速普及也体现在行业业绩上。士卓曼集团于2025年2月发布的2024年度报告显示，其数位化解决方案业务在全球实现了两位数的收入成长。这一增长印证了数位化互联正成为常规植入和再生手术的标准组成部分。

同时，合成骨材和异种移植材料的使用正在加速发展，逐渐取代传统的自体骨移植在骨增量手术的应用。这项转变的驱动力主要来自临床目标，即最大限度地减少与二次手术部位相关的患者併发症，以及高品质、即用型生物材料的普及，这些材料能够提供有效的骨传导支架。这一趋势的商业性影响在财务表现中显而易见。根据亨利·谢恩公司于2025年2月发布的“2024财年第四季度及全年财务业绩”，其全球特种产品部门（包括生物材料）的销售额达到14亿美元，同比增长8.7%。这一增长表明，作为自体骨移植的替代方案，这些便捷的重组材料的需求持续强劲增长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球牙科骨移植替代材料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（同种异体移植、异质骨移植、自体移植、合成骨移植、其他）
  • 依材料分类（人源细胞、胶原蛋白、动物性、其他）
  • 透过作用机转（骨传导、骨诱导、骨促进、骨形成）
  • 副产品（BioOSS、Grafton、Osteograph）
  • 依应用领域（齿槽窝保存、齿槽嵴增高、牙周缺损再生、植入骨再生、鼻窦增高术）
  • 依最终使用者（医院/诊所、牙体技术所、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美牙科骨移植替代材料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲牙科骨移植替代材料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区牙科骨移植替代材料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲牙科骨移植替代材料市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲牙科骨移植替代材料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球牙科骨移植替代材料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Dentsply Sirona Inc.
• ZimVie Inc.
• Medtronic plc
• Institut Straumann AG
• Geistlich Pharma AG
• BioHorizons Inc.
• NovaBone Products, LLC
• Botiss Biomaterials GmbH
• LifeNet Health, Inc.
• RTI Surgical Holdings, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dental Bone Graft Substitute Market is projected to experience substantial growth, expanding from USD 908.28 Million in 2025 to USD 1416.68 Million by 2031 at a CAGR of 7.69%. These specialized biomaterials function as scaffolds to facilitate natural bone regeneration, playing a critical role in restorative treatments such as dental implant placement and periodontal therapy to correct bone defects. This expansion is primarily driven by the rising global demand for tooth replacement solutions and the growing prevalence of periodontal diseases in an aging population. Underscoring the scale of this clinical need, the European Federation of Periodontology reported in 2024 that the treatment of preventable oral conditions, including periodontitis and caries, accounted for roughly 5% of global healthcare expenditures, highlighting the significant burden requiring effective restorative interventions.

However, despite strong demand, the market faces a major restraint due to the high cost of regenerative procedures and the frequent lack of comprehensive reimbursement policies. In many regions, insurance providers do not fully cover these advanced treatments, leading to substantial out-of-pocket expenses that limit patient access, particularly in emerging economies. As a result, affordability issues prevent the widespread adoption of premium bone graft substitutes among lower-income demographics. This economic barrier hampers market potential in cost-sensitive areas, restricting the reach of advanced grafting therapies to primarily affluent patient segments.

Market Driver

A primary catalyst for the bone graft substitute market is the surging global demand for dental implant procedures, which has established a direct dependency between implant adoption and the need for bone regeneration materials. Since adequate bone volume is essential for implant stability, the prevalence of ridge deficiencies necessitates the concurrent use of bone grafts, making them integral to modern restorative dentistry. This trend is reflected in the financial success of key industry players; for instance, Straumann Group's 'Full Year 2024 Annual Report', released in February 2025, reported revenues of CHF 2.5 billion with 13.7% organic growth, driven largely by its robust implantology business. Furthermore, the American Dental Association noted in 2025 that U.S. consumer dental spending rose by 4% through August, indicating sustained patient investment in restorative oral healthcare.

The second critical driver is the expanding geriatric population and the associated rise in edentulism and severe periodontal conditions. Aging naturally leads to alveolar bone resorption and increased susceptibility to oral diseases that compromise jaw structure, thereby fueling the necessity for reconstructive bone therapy. Severe periodontitis remains a pervasive global health challenge; the World Health Organization's 'Oral Health' fact sheet from March 2025 estimated that over 1 billion cases of severe periodontal disease exist worldwide. This vast scale of pathology highlights the urgent need for regenerative interventions, ensuring that as the global population ages and faces complex oral health issues, the reliance on effective bone graft substitutes for rehabilitation will continue to intensify.

Market Challenge

The most significant impediment to the growth of the Global Dental Bone Graft Substitute Market is the prohibitive cost of regenerative procedures coupled with the absence of adequate reimbursement frameworks. Many insurance providers classify advanced bone grafting as an elective or cosmetic service rather than a medical necessity, forcing patients to shoulder significant out-of-pocket costs. This financial burden severely restricts market penetration, as a large portion of the patient population is compelled to choose less expensive, non-restorative alternatives or delay treatment indefinitely. Consequently, the adoption of bone graft substitutes is often limited to wealthier demographics, preventing the market from realizing its full volume potential in emerging and cost-sensitive economies.

This economic barrier leads to a quantifiable decrease in patient engagement with professional dental services, creating a bottleneck for specialized care. According to the American Dental Association in 2024, dental care presented the highest cost barriers compared to other health services, contributing to a utilization rate where only 40% of working-age adults visited a dentist. This statistic underscores a direct link between high costs and low service uptake; when patients are unable to afford basic access to dental professionals due to financial constraints, the downstream demand for sophisticated, high-cost procedures like bone grafting is inevitably throttled, thereby stalling overall market expansion.

Market Trends

A major trend reshaping the market is the convergence of digital workflow and guided bone regeneration technologies, which are enhancing clinical precision and outcomes. By integrating cone-beam computed tomography (CBCT) and intraoral scanning, clinicians can leverage software-driven tools to calculate exact bone volume requirements and fabricate custom surgical guides, significantly improving the predictability of complex ridge augmentations. The rapid adoption of this technology is evidenced by industry performance; Straumann Group's 'Annual Report 2024', published in February 2025, highlighted double-digit revenue growth in its digital solutions business globally. This expansion confirms that digitized interconnectivity is becoming a standard component of routine implant and regenerative procedures.

Concurrently, there is an accelerated shift toward the use of synthetic and xenograft materials, which are displacing traditional autogenous bone harvesting as the preferred standard for augmentation. This transition is driven by the clinical goal of minimizing patient morbidity associated with secondary surgical sites and the availability of high-quality, off-the-shelf biomaterials that offer effective osteoconductive scaffolds. The commercial impact of this preference is clear in financial results; Henry Schein's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025 reported that their Global Specialty Products segment, encompassing biomaterials, achieved sales of $1.4 billion-an 8.7% increase from the prior year. This growth highlights the sustained momentum in the consumption of these convenient reconstructive materials over autografts.

Key Market Players

• Dentsply Sirona Inc.
• ZimVie Inc.
• Medtronic plc
• Institut Straumann AG
• Geistlich Pharma AG
• BioHorizons Inc.
• NovaBone Products, LLC
• Botiss Biomaterials GmbH
• LifeNet Health, Inc.
• RTI Surgical Holdings, Inc.

Report Scope

In this report, the Global Dental Bone Graft Substitute Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dental Bone Graft Substitute Market, By Type

• Allograft
• Xenograft
• Autograft
• Synthetic Bone Graft
• Others

Dental Bone Graft Substitute Market, By Material

• Human Cell Source
• Collagen
• Animal Source
• Others

Dental Bone Graft Substitute Market, By Mechanism

• Osteoconduction
• Osteoinduction
• Osteopromotion
• Osteogenesis

Dental Bone Graft Substitute Market, By Product

• Bio OSS
• Grafton
• Osteograf

Dental Bone Graft Substitute Market, By Application

• Socket Preservation
• Ridge Augmentation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift

Dental Bone Graft Substitute Market, By End User

• Hospitals & Clinics
• Dental Laboratories
• Others

Dental Bone Graft Substitute Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dental Bone Graft Substitute Market.

Available Customizations:

Global Dental Bone Graft Substitute Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dental Bone Graft Substitute Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Allograft, Xenograft, Autograft, Synthetic Bone Graft, Others)
  • 5.2.2. By Material (Human Cell Source, Collagen, Animal Source, Others)
  • 5.2.3. By Mechanism (Osteoconduction, Osteoinduction, Osteopromotion, Osteogenesis)
  • 5.2.4. By Product (Bio OSS, Grafton, Osteograf)
  • 5.2.5. By Application (Socket Preservation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift)
  • 5.2.6. By End User (Hospitals & Clinics, Dental Laboratories, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2025)
• 5.3. Market Map

6. North America Dental Bone Graft Substitute Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Material
  • 6.2.3. By Mechanism
  • 6.2.4. By Product
  • 6.2.5. By Application
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dental Bone Graft Substitute Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By Mechanism
      • 6.3.1.2.4. By Product
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Dental Bone Graft Substitute Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By Mechanism
      • 6.3.2.2.4. By Product
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Dental Bone Graft Substitute Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By Mechanism
      • 6.3.3.2.4. By Product
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By End User

7. Europe Dental Bone Graft Substitute Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Material
  • 7.2.3. By Mechanism
  • 7.2.4. By Product
  • 7.2.5. By Application
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dental Bone Graft Substitute Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By Mechanism
      • 7.3.1.2.4. By Product
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By End User
  • 7.3.2. France Dental Bone Graft Substitute Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By Mechanism
      • 7.3.2.2.4. By Product
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By End User
  • 7.3.3. United Kingdom Dental Bone Graft Substitute Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By Mechanism
      • 7.3.3.2.4. By Product
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By End User
  • 7.3.4. Italy Dental Bone Graft Substitute Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By Mechanism
      • 7.3.4.2.4. By Product
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Dental Bone Graft Substitute Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By Mechanism
      • 7.3.5.2.4. By Product
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By End User

8. Asia Pacific Dental Bone Graft Substitute Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Material
  • 8.2.3. By Mechanism
  • 8.2.4. By Product
  • 8.2.5. By Application
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dental Bone Graft Substitute Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By Mechanism
      • 8.3.1.2.4. By Product
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By End User
  • 8.3.2. India Dental Bone Graft Substitute Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By Mechanism
      • 8.3.2.2.4. By Product
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Dental Bone Graft Substitute Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By Mechanism
      • 8.3.3.2.4. By Product
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Dental Bone Graft Substitute Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By Mechanism
      • 8.3.4.2.4. By Product
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Dental Bone Graft Substitute Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By Mechanism
      • 8.3.5.2.4. By Product
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By End User

9. Middle East & Africa Dental Bone Graft Substitute Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Material
  • 9.2.3. By Mechanism
  • 9.2.4. By Product
  • 9.2.5. By Application
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dental Bone Graft Substitute Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By Mechanism
      • 9.3.1.2.4. By Product
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By End User
  • 9.3.2. UAE Dental Bone Graft Substitute Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By Mechanism
      • 9.3.2.2.4. By Product
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By End User
  • 9.3.3. South Africa Dental Bone Graft Substitute Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By Mechanism
      • 9.3.3.2.4. By Product
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By End User

10. South America Dental Bone Graft Substitute Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Material
  • 10.2.3. By Mechanism
  • 10.2.4. By Product
  • 10.2.5. By Application
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dental Bone Graft Substitute Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By Mechanism
      • 10.3.1.2.4. By Product
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By End User
  • 10.3.2. Colombia Dental Bone Graft Substitute Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By Mechanism
      • 10.3.2.2.4. By Product
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By End User
  • 10.3.3. Argentina Dental Bone Graft Substitute Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By Mechanism
      • 10.3.3.2.4. By Product
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dental Bone Graft Substitute Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dentsply Sirona Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. ZimVie Inc.
• 15.3. Medtronic plc
• 15.4. Institut Straumann AG
• 15.5. Geistlich Pharma AG
• 15.6. BioHorizons Inc.
• 15.7. NovaBone Products, LLC
• 15.8. Botiss Biomaterials GmbH
• 15.9. LifeNet Health, Inc.
• 15.10. RTI Surgical Holdings, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer